<DOC>
	<DOC>NCT01788540</DOC>
	<brief_summary>Intralipid infusion can improve the outcome in NK cells positive females with history of recurrent miscarriages undergoing IVF/ICSI cycles.</brief_summary>
	<brief_title>Intralipid for Recurrent Miscarriage</brief_title>
	<detailed_description />
	<mesh_term>Abortion, Spontaneous</mesh_term>
	<mesh_term>Abortion, Habitual</mesh_term>
	<mesh_term>Soybean oil, phospholipid emulsion</mesh_term>
	<criteria>Couples with unexplained secondary infertility Three or more prior consecutive clinical miscarriages after either spontaneous pregnancy or after IVF/ICSI. Elevated natural killer (NK) cells CD16, CD56 and cells with both CD16/CD56 &gt;12%. Age above forty years old. Antiphospholipid syndrome (lupus anticoagulant and/or anticardiolipin antibodies [IgG or IgM]); other recognised thrombophilic conditions (testing according to usual clinic practice). Intrauterine abnormalities (as assessed by ultrasound, hysterosonography, hysterosalpingogram, or hysteroscopy). Abnormal parental karyotype. Other identifiable causes of recurrent miscarriages (tests initiated only if clinically indicated) e.g., diabetes, thyroid disease and systemic lupus erythematosus (SLE). Disturbances of normal fat metabolism such as pathologic hyperlipemia Allergic to it; or to eggs, soybean oil, or safflower oil. Severe liver disease, kidney disease, lung disease, anemia, blood clotting disorder.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Recurrent miscarriage</keyword>
	<keyword>Implantation failure</keyword>
	<keyword>Intralipid</keyword>
	<keyword>ICSI / IVF failure</keyword>
</DOC>